SKI Market

Indian Indices

Sensex

83,674.92 -558.72
( -0.66%)

Global Indices

Nasdaq

50,155.23 -53.92
(-0.11%)

Dow Jones

6,964.65 1.84
(0.03%)

Hang Seng

57,686.98 36.44
(0.06%)

Nikkei 225

10,413.72 -58.39
(-0.56%)

Forex

USD-INR

90.60 -0.06
(-0.06%)

EUR-INR

107.84 0.20
(0.18%)

GBP-INR

123.81 0.16
(0.13%)

JPY-INR

0.58 0.00
(0.79%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.5631051

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

22.85

106023.09

EPS(TTM)

Face Value()

Div & Yield %

55.59

0.63

Back

alliance integrated metaliks ltd

Genpharmasec standalone net profit declines 18.00% in the September 2025 quarter

Nov 07,2025

Net profit of Genpharmasec declined 18.00% to Rs 0.82 crore in the quarter ended September 2025 as against Rs 1.00 crore during the previous quarter ended September 2024. Sales rose 446.97% to Rs 31.56 crore in the quarter ended September 2025 as against Rs 5.77 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	31.56	5.77	447
OPM %	1.62	4.33	-
PBDT	1.43	1.07	34
PBT	1.39	1.03	35
NP	0.82	1.00	-18

83,674.92 -558.72 ( -0.66%)

50,155.23 -53.92 (-0.11%)

6,964.65 1.84 (0.03%)

57,686.98 36.44 (0.06%)

10,413.72 -58.39 (-0.56%)

90.60 -0.06 (-0.06%)

107.84 0.20 (0.18%)

123.81 0.16 (0.13%)

0.58 0.00 (0.79%)